PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency

Archives of Oral Biology

Volumn 48, Issue 6, 2003, Pages 415-422

  Ellies, L G ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hyperplasia; Inducible nitric oxide synthase; Lectins; Mice; Parotid gland; Polyomavirus middle T antigen; Premalignant

Indexed keywords

ARACHIS HYPOGAEA; POLYOMAVIRUS;

EID: 0038248953     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(03)00085-2     Document Type: Article

References (35)

1. Ellis GL, Auclair PL. Tumours of the salivary glands. Washington: Armed Forces Institute of Pathology; 1996.
2. Gross L. Filterable agent recovered from AK leukemic extract causing salivary gland carcinoma in C3H mice. Proc Soc Exp Biol Med 1953;83:414-21.
3. Imperiale MJ. Oncogenic transformation by the human polyomaviruses. Oncogene 2001;20:7917-23.
4. Barthold SW. Polyoma virus infection, salivary glands, mouse. In: Jones T, Mohr U, Hunt RD, editors. Digestive system. Monographs on pathology of laboratory animals. Berlin: Springer-Verlag; 1985. p. 193-6.
5. Dawe CJ, Morgan WD, Slatick MS. Influence of epitheliomesenchymal interactions on tumour induction by polyoma virus. Int J Cancer 1966;1:419-50.
6. Kiefer F, Courtneidge SA, Wagner EF. Oncogenic properties of the middle T antigens of polyomaviruses. Adv Cancer Res 1994;64:125-57.
7. Ichaso N, Dilworth SM. Cell transformation by the middle T-antigen of polyoma virus. Oncogene 2001;20:7908-16.
8. Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI, et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 2002;99:6967-72.
9. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994;54:5675-82.
10. Guy C, Cardiff R, Muller W. Induction of mammary tumours by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-61.
11. Zebda N, Bailly M, Brown S, Dore JF, Berthier-Vergnes O. Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 1994;54:161-73.
12. Springer GF. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 1997;75:594-602.
13. Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, et al. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett 2000;469:24-8.
14. Ellies LG, Fishman M, Hardison J, Kleeman J, Maglione J, Manner CK, et al. Mammary tumour latency is increased in mice lacking the inducible nitric oxide synthase. Int J Cancer 2003; in press.
15. Lala PK, Orucevic A. Role of nitric oxide in tumour progression: lessons from experimental tumours. Cancer Metast Rev 1998;17:91-106.
16. Bentz BG, Haines III GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue. Head Neck 1998;20:304-9.
17. Brennan PA, Umar T, Buckley J, Zaki GA, Langdon JD, Spedding A, et al. Expression of nitric oxide synthase in pleomorphic adenomas of the parotid. Br J Oral Maxillofac Surg 2000;38:338-42.
18. Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999;70:222-9.
19. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171-4.
20. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995;113:541-9.
21. Thomsen LL, Miles DW, Happerfield L, Bowbrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.
22. Vickers SM, MacMillan-Crow LA, Green M, Ellis C, Thompson JA. Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg 1999;134:245-51.
23. Laubach V, Shesely E, Smithies O, Sherman P. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. PNAS (USA) 1995;92:10688-92.
24. Murase N, Takai Y, Hosaka M, Asano K, Mori M. Lectin-binding in premalignant lesions during submandibular gland carcinogenesis. J Oral Pathol 1984;13:505-15.
25. Rosignoli F, Goren NB, Perez Leiros C. Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice. Clin Immunol 2001;101:86-93.
26. Mashimo H, Goyal RK. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol 1999;277:G745-50.
27. Larson DL. Management of the recurrent, benign tumour of the parotid gland. Plast Reconstr Surg 2001;108:734-40.
28. Weinstein GS, Conley JJ. Adenoid cystic carcinoma of the parotid gland: a review of surgical management with reference to the facial nerve. Ann Otol Rhinol Laryngol 1989;98:845-7.
29. Andrechek ER, Muller WJ. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res 2000;2:211-6.
30. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988;54:105-15.
31. Maglione J, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph S, et al. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001;61:8298-305.
32. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 2000;19:5338-47.
33. Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX. Inactivation of p53 tumour suppressor gene acts synergistically with c-neu oncosene in salivary gland tumorigenesis. Oncogene 2001;20:1445-54.
34. Wick MR, Swanson PE. Primary adenoid cystic carcinoma of the skin. A clinical, histological, and immunocytochemical comparison with adenoid cystic carcinoma of salivary glands and adenoid basal cell carcinoma. Am J Dermatopathol 1986;8:2-13.
35. Brinkman-Van der Linden EC, Sonnenburg JL, Varki A. Effects of sialic acid substitutions on recognition by Sambucus nigra agglutinin and Maackia amurensis hemagglutinin. Anal Biochem 2002;303:98-104.